Quality of life in patients with B-cell lymphoma during maintenance therapy with the Anti-CD20 antibody rituximab

被引：0
|
作者：
Witzens-Harig, Mathias [1 ]
Heiss, Christiane [2 ]
Benner, Axel [2 ]
Hensel, Manfred [1 ]
Neben, Kai [1 ]
Dreger, Peter [1 ]
Kraemer, Alwin [1 ]
Ho, Anthony D. [1 ]
机构：
[1] Univ Heidelberg, Dept Hematol & Oncol, Heidelberg, Germany
[2] German Canc Res Ctr, Dept Biostat, Heidelberg, Germany
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.4471.4471
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4471
引用
收藏
页码：189B / 189B
页数：1
相关论文
共 50 条
  • [41] Feasibility and pharmacokinetic study of a chimeric anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) in relapsed B-cell lymphoma
    Tobinai, K
    Kobayashi, Y
    Narabayashi, M
    Ogura, M
    Kagami, Y
    Morishima, Y
    Ohtsu, T
    Igarashi, T
    Sasaki, Y
    Kinoshita, T
    Murate, T
    ANNALS OF ONCOLOGY, 1998, 9 (05) : 527 - 534
  • [42] Peripheral T-cell lymphoma after anti-CD20 antibody therapy
    Tetreault, S
    Abler, SL
    Robbins, B
    Saven, A
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) : 1635 - 1636
  • [43] Mechanism of action on B cell lymphoma by chimeric anti-CD20 monoclonal antibody
    T Oyama
    Y Kagami
    M Seto
    Y Morishima
    Leukemia, 2001, 15 : 1667 - 1667
  • [44] Mechanism of action on B cell lymphoma by chimeric anti-CD20 monoclonal antibody
    Oyama, T
    Kagami, Y
    Seto, M
    Morishima, Y
    LEUKEMIA, 2001, 15 (10) : 1667 - 1667
  • [45] Treatment of B-cell non-Hodgkin's lymphoma with anti CD 20 monoclonal antibody Rituximab
    Sacchi, S
    Federico, M
    Dastoli, G
    Fiorani, C
    Vinci, G
    Clò, V
    Casolari, B
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2001, 37 (01) : 13 - 25
  • [46] Systemic eight-cycle anti-CD20 monoclonal antibody (rituximab) therapy in primary cutaneous B-cell lymphomas - an applicational observation
    Gellrich, S
    Muche, JM
    Wilks, A
    Jasch, KC
    Voit, C
    Fischer, T
    Audring, H
    Sterry, W
    BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 (01) : 167 - 173
  • [47] Experimental treatment of human diffuse large B-cell lymphoma xenografts by doxycycline alone or in combination with the anti-CD20 chimeric monoclonal antibody rituximab
    Assayag, Franck
    Brousse, Nicole
    Couturier, Jerome
    Macintyre, Elizabeth
    Mathiot, Claire
    Dewulf, Sebastien
    Froget, Benoit
    Vincent-Salomon, Anne
    Decaudin, Didier
    AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (06) : 387 - 388
  • [48] High Expression of CXCR4 Impairs Anti-CD20 Monoclonal Antibody (Rituximab)-Dependent Cytotoxicity in Diffuse Large B-Cell Lymphoma
    Reinholdt, Linn Ronlev
    Laursen, Maria Bach
    Falgreen, Steffen
    Schmitz, Alexander
    Bodker, Julie Stove
    Boegsted, Martin
    Johnsen, Hans Erik
    Dybkaer, Karen
    BLOOD, 2015, 126 (23)
  • [49] Therapy of refractory pemphigus vulgaris with monoclonal anti-CD20 antibody (rituximab)
    Morrison, LH
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 51 (05) : 817 - 819
  • [50] Ofatumumab, a Novel Anti-CD20 Monoclonal Antibody for the Treatment of B-Cell Malignancies
    Cheson, Bruce D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (21) : 3525 - 3530
12345